ARTG 327278Juvederm VOLUX - Synthetic-fluid tissue reconstructive material, anaesthetic
ARTG ID: 327278 · Abbvie Pty Ltd · Allergan · Class III · Started December 10, 2019
Good Name: Abbvie Pty Ltd - Juvederm VOLUX - Synthetic-fluid tissue reconstructive material, anaesthetic
- Risk Class
- Class III
- Product Type
- Single Device Product
- ARTG Category
- General
- ARTG ID
- 327278
- Start Date
- December 10, 2019
- Effective Date
- December 10, 2019
- Name
- Abbvie Pty Ltd
- Name
- Allergan
- Country
- France
- Address
- Route de Promery , Zone Artisanale de Pre Mairy, Pringy, Annecy, 74370
Juvéderm® VOLUX™ is an injectable implant intended to restore and create volume of the face. The presence of lidocaine is meant to reduce the patient’s pain during treatment.
Access comprehensive regulatory information for Juvederm VOLUX - Synthetic-fluid tissue reconstructive material, anaesthetic in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 327278 and sponsored by Abbvie Pty Ltd, manufactured by Allergan in France. The device registration started on December 10, 2019.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.